BEATW
Heartbeam Inc. WarrantKey Statistics
About Heartbeam Inc. Warrant
Heartbeam Inc. Warrant (BEATW) represents a strategic investment aligned with Heartbeam Inc., a pioneering healthcare technology firm focused on transforming cardiac diagnostics through the integration of artificial intelligence and digital solutions. The company's cutting-edge platform enhances diagnostic precision for myocardial infarctions, facilitating timely interventions that significantly improve patient care outcomes. As the demand for innovative remote monitoring and telehealth services continues to escalate, Heartbeam is well-positioned to capture substantial market growth, making BEATW an appealing opportunity for institutional investors seeking to invest in transformative healthcare technologies with significant potential.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -164.20% |
| Return on Assets | -90.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.30 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $5.19M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BEATW and any ticker you trade — then tracks every position and per-strategy win rate.